Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study links specific cancer driver mutations to mutational signatures, revealing how these genetic changes arise during cancer development. Understanding these associations aids in exploring cancer pathogenesis and guiding future research.
Area Of Science
- Genomics
- Cancer Biology
- Computational Biology
Background
- Driver mutations are key genetic variants in oncogenesis, but their origins are unclear.
- Mutational signatures, based on trinucleotide frequencies, help investigate cancer's underlying mutational processes.
Purpose Of The Study
- To statistically link specific driver mutations with known mutational signatures across diverse cancer types.
- To uncover novel relationships between mutagenic processes and driver mutation acquisition in cancer development.
Main Methods
- Analysis of somatic mutations from 7,815 The Cancer Genome Atlas (TCGA) exomes across 26 cancer types.
- Curated list of 50 driver mutations and binary univariate logistic regression to assess associations with mutational signatures.
- Validation of methodology using known associations and examination of novel links, including negative associations.
Main Results
- Identified 39 significant associations between driver mutations and mutational signatures (P < 0.004, FDR < 5%).
- Validated links for Polymerase Epsilon proofreading deficiency, AID/APOBEC activity, and mismatch repair deficiency.
- Uncovered negative associations, exploring roles of aging and smoking in IDH1 and KRAS mutations.
Conclusions
- Provides statistical evidence for hypothesized links between biological processes and mutational signatures.
- Reveals previously unexplored relationships guiding mechanistic studies in cancer pathogenesis.
- Offers insights into how cancers acquire advantageous mutations.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumors may result in a case where two people have the same mutations in an oncogene or tumor...
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...